Literature DB >> 11479015

Liposome-mediated gene transfer to fetal human ventral mesencephalic explant cultures.

M Bauer1, M Meyer, J Sautter, T Gasser, M Ueffing, H R Widmer.   

Abstract

The feasibility of non-viral gene transfer using liposomes is described for human fetal nigral tissue. Ventral mesencephalic explants from 6 to 12 week old fetuses were grown as free-floating roller tube cultures. For the transfection, a vector coding for beta-galactosidase driven by the Rous Sarcoma Virus promoter was used. The developmental stage of the human tissue, time in vitro and the amount of vector DNA used significantly influenced the transfection efficiency. Optimal transfection results were obtained with tissue from a 10 week old fetus, cultured for 4 days and transfected with mixtures containing 4 microg vector DNA. Histological analysis suggested that a specific population of ventral mesencephalic precursor cells were the target for the gene transfer. This finding might have implications for gene delivery and cell replacement strategies in Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11479015     DOI: 10.1016/s0304-3940(01)01999-1

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

Review 1.  Reverse genetics for proteomics: from proteomic discovery to scientific content.

Authors:  M Bauer; M Ueffing
Journal:  J Neural Transm (Vienna)       Date:  2006-07-13       Impact factor: 3.575

Review 2.  Investigating the mechanisms underlying neuronal death in ischemia using in vitro oxygen-glucose deprivation: potential involvement of protein SUMOylation.

Authors:  Helena Cimarosti; Jeremy M Henley
Journal:  Neuroscientist       Date:  2008-12       Impact factor: 7.519

3.  Comparison of ectopic gene expression methods in rat neural stem cells.

Authors:  Woosuk Kim; Ji Hyeon Kim; Sun-Young Kong; Min-Hye Park; Uy Dong Sohn; Hyun-Jung Kim
Journal:  Korean J Physiol Pharmacol       Date:  2013-02-14       Impact factor: 2.016

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.